Related references
Note: Only part of the references are listed.Serum cortisol and insulin-like growth factor 1 levels in major depressive disorder and schizophrenia
Hiroshi Arinami et al.
SCIENTIFIC REPORTS (2023)
IGF2 inhibits hippocampal over-activated microglia and alleviates depression-like behavior in LPS- treated male mice
Dongming Guo et al.
BRAIN RESEARCH BULLETIN (2023)
Insulin-like growth factor 2 and autophagy gene expression alteration arise as potential biomarkers in Parkinson's disease
Denisse Sepulveda et al.
SCIENTIFIC REPORTS (2022)
Insulin-like Growth Factor 2 (IGF-2) and Insulin-like Growth Factor Binding Protein 7 (IGFBP-7) Are Upregulated after Atypical Antipsychotics in Spanish Schizophrenia Patients
Carlos Fernandez-Pereira et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
The Roles of Insulin-Like Growth Factor Binding Protein Family in Development and Diseases
Fei Song et al.
ADVANCES IN THERAPY (2021)
Onset and frequency of depression in post-COVID-19 syndrome: A systematic review
Olivier Renaud-Charest et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2021)
Insulin-Like Growth Factor 2 As a Possible Neuroprotective Agent and Memory Enhancer-Its Comparative Expression, Processing and Signaling in Mammalian CNS
Alexander Beletskiy et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Depression: Biological markers and treatment
Gordana Nedic Erjavec et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2021)
Association Between Serum Insulin-Like Growth Factor 1 Levels and the Clinical Symptoms of Chronic Schizophrenia: Preliminary Findings
Naomichi Okamoto et al.
FRONTIERS IN PSYCHIATRY (2021)
Evaluation of IGF-1 as a novel theranostic biomarker for schizophrenia
Umit Haluk Yesilkaya et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2021)
Insulin-Like Growth Factor Pathway and the Thyroid
Terry J. Smith
FRONTIERS IN ENDOCRINOLOGY (2021)
The association between serum insulin-like growth factor 1 and cognitive impairments in patients with schizophrenia
Chao Xue-lin et al.
PSYCHIATRY RESEARCH (2020)
Serum insulin-like growth factor-1 as a potential marker for MDD diagnosis, its clinical characteristics, and treatment efficacy validation: data from an open-label vortioxetine study
Oleg A. Levada et al.
BMC PSYCHIATRY (2020)
Altered insulin-like growth factor-2 signaling is associated with psychopathology and cognitive deficits in patients with schizophrenia
Yuan-Jian Yang et al.
PLOS ONE (2020)
Insulin Growth Factor Binding Protein 7 (IGFBP7)-Related Cancer and IGFBP3 and IGFBP7 Crosstalk
Li Jin et al.
FRONTIERS IN ONCOLOGY (2020)
Insulin-like growth factor 2 (IGF2) protects against Huntington's disease through the extracellular disposal of protein aggregates
Paula Garcia-Huerta et al.
ACTA NEUROPATHOLOGICA (2020)
Changes of Serum Insulin-like Growth Factor-2 Response to Negative Symptom Improvements in Schizophrenia Patients Treated with Atypical Antipsychotics
Xue-lin Chao et al.
CURRENT MEDICAL SCIENCE (2020)
Understanding IGF-II Action through Insights into Receptor Binding and Activation
Andrew J. Blyth et al.
CELLS (2020)
Disorders of IGFs and IGF-1R signaling pathways
Briony E. Forbes et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2020)
Neurotrophic factors in bipolar disorders patients with manic episode
Ozgur Korhan Tuncel et al.
TURKISH JOURNAL OF MEDICAL SCIENCES (2020)
Peripheral IGF-1 in bipolar disorder and major depressive disorder: a systematic review and meta-analysis
Mengyi Chen et al.
ANNALS OF PALLIATIVE MEDICINE (2020)
Insulin growth factor 2 (IGF2) as an emergent target in psychiatric and neurological disorders. Review
M. Pardo et al.
NEUROSCIENCE RESEARCH (2019)
Risk factors for Alzheimer's disease
Richard A. Armstrong
FOLIA NEUROPATHOLOGICA (2019)
Impact of extremely low-birth-weight status on risk and resilience for depression and anxiety in adulthood
Ryan J. Van Lieshout et al.
JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY (2018)
IGF-binding proteins
L. A. Bach
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2018)
Insulin-like growth factor binding protein 2 in bipolar disorder: An expression study in peripheral tissues
Elena Milanesi et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2018)
Blood biomarkers and treatment response in major depression
Cristina Mora et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2018)
Peripheral biomarkers of major depression and antidepressant treatment response: Current knowledge and future outlooks
Bharathi S. Gadad et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
Peripheral insulin-like growth factor 1 in bipolar disorder
Emily G. da Silva et al.
PSYCHIATRY RESEARCH (2017)
Biomarcadores en Psiquiatría: entre el mito y la realidad clínica
J. Javier Meana et al.
Revista de Psiquiatria y Salud Mental (2017)
Serum Levels of Insulin-Like Growth Factor-1 and Obsessive-Compulsive Disorder: A Case-Control Study
Gianluca Rosso et al.
NEUROPSYCHOBIOLOGY (2016)
Assessing anhedonia in depression: Potentials and pitfalls
Sakina J. Rizvi et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2016)
Plasma insulin-like growth factor I levels are higher in depressive and anxiety disorders, but lower in antidepressant medication users
Mariska Bot et al.
PSYCHONEUROENDOCRINOLOGY (2016)
The effects of maternal anxiety during pregnancy on IGF2/H19 methylation in cord blood
T. Mansell et al.
TRANSLATIONAL PSYCHIATRY (2016)
Serum proteomic profiles of depressive subtypes
F. Lamers et al.
TRANSLATIONAL PSYCHIATRY (2016)
Insulin-like growth factor binding-protein-3 (IGFBP-3)
Michael B. Ranke
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
A Systematic Review of Depression
Ranji Cui
CURRENT NEUROPHARMACOLOGY (2015)
IGF-I in major depression and antidepressant treatment response
Anna Kopczak et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
DNA methylation in imprinted genes IGF2 and GNASXL is associated with prenatal maternal stress
E. B. Vangeel et al.
GENES BRAIN AND BEHAVIOR (2015)
Insulin-like growth factor 2 mitigates depressive behavior in a rat model of chronic stress
Yan-Wei Luo et al.
NEUROPHARMACOLOGY (2015)
Genome-wide methylation study on depression: differential methylation and variable methylation in monozygotic twins
A. Cordova-Palomera et al.
TRANSLATIONAL PSYCHIATRY (2015)
Increased Cerebrospinal Fluid Level of Insulin-like Growth Factor-II in Male Patients with Alzheimer's Disease
Daniel Aberg et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
The Free and Cued Selective Reminding Test Distinguishes Frontotemporal Dementia From Alzheimer's Disease
Raquel Lemos et al.
ARCHIVES OF CLINICAL NEUROPSYCHOLOGY (2014)
Changes in cerebrospinal fluid and blood plasma levels of IGF-II and its binding proteins in Alzheimer's disease: an observational study
Joakim Hertze et al.
BMC NEUROLOGY (2014)
Generating new neurons to circumvent your fears: the role of IGF signaling
R. C. Agis-Balboa et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Relationships between IGF-1, schizophrenia, and treatment of metabolic syndrome
Aysegul Demirel et al.
COMPREHENSIVE PSYCHIATRY (2014)
Hippocampal gene expression in a rat model of depression after electroacupuncture at the Baihui and Yintang acupoints
Dongmei Duan et al.
NEURAL REGENERATION RESEARCH (2014)
Insulin growth factor binding protein 7 is a novel target to treat dementia
Hope Y. Agbemenyah et al.
NEUROBIOLOGY OF DISEASE (2014)
Low birth-weight and risk for major depression: A community-based longitudinal study
Stephen Z. Levine
PSYCHIATRY RESEARCH (2014)
Elevated serum levels of FGF-2, NGF and IGF-1 in patients with manic episode of bipolar disorder
Xiaohua Liu et al.
PSYCHIATRY RESEARCH (2014)
Emerging evidence of insulin-like growth factor 2 as a memory enhancer: a unique animal model of cognitive dysfunction with impaired adult neurogenesis
Takashi Iwamoto et al.
REVIEWS IN THE NEUROSCIENCES (2014)
IGF binding proteins in cancer: mechanistic and clinical insights
Robert C. Baxter
NATURE REVIEWS CANCER (2014)
High insulin-like growth factor-1 in patients with bipolar I disorder: A trait marker?
Yong-Ku Kim et al.
JOURNAL OF AFFECTIVE DISORDERS (2013)
Relationship between negative symptoms and plasma levels of insulin-like growth factor 1 in first-episode schizophrenia and bipolar disorder patients
Aitor Palomino et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2013)
Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer's disease
Per Johansson et al.
PSYCHONEUROENDOCRINOLOGY (2013)
Diurnal alterations in circadian genes and peptides in major depressive disorder before and after escitalopram treatment
Su-Xia Li et al.
PSYCHONEUROENDOCRINOLOGY (2013)
IGF-I, IGF-II, and Insulin Stimulate Different Gene Expression Responses through Binding to the IGF-I Receptor
Soetkin Versteyhe et al.
Frontiers in Endocrinology (2013)
The neuronal insulin sensitizer dicholine succinate reduces stress-induced depressive traits and memory deficit: possible role of insulin-like growth factor 2
Brandon H. Cline et al.
BMC NEUROSCIENCE (2012)
Decreased expression of extracellular matrix proteins and trophic factors in the amygdala complex of depressed mice after chronic immobilization stress
Soonwoong Jung et al.
BMC NEUROSCIENCE (2012)
Depression in pregnancy, infant birth weight and DNA methylation of imprint regulatory elements
Ying Liu et al.
EPIGENETICS (2012)
IGF2 DNA methylation is a modulator of newborn's fetal growth and development
Julie St-Pierre et al.
EPIGENETICS (2012)
Neurodevelopmental effects of insulin-like growth factor signaling
John O'Kusky et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2012)
Insulin-Like Growth Factor-I and Insulin-Like Growth Factor Binding Protein-3 in Alzheimer's Disease
Emmanuelle Duron et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
A hippocampal insulin-growth factor 2 pathway regulates the extinction of fear memories
Roberto Carlos Agis-Balboa et al.
EMBO JOURNAL (2011)
A critical role for IGF-II in memory consolidation and enhancement
Dillon Y. Chen et al.
NATURE (2011)
IGF-I gene variability is associated with an increased risk for AD
Teo Vargas et al.
NEUROBIOLOGY OF AGING (2011)
Effect of antipsychotic treatment on Insulin-like Growth Factor-1 and cortisol in schizophrenia: A longitudinal study
Ganesan Venkatasubramanian et al.
SCHIZOPHRENIA RESEARCH (2010)
Insulin-like Growth Factor-I (IGF-I) Serum Concentrations in Depressed Patients: Relationship to Saliva Cortisol and Changes during Antidepressant Treatment
B. Weber-Hamann et al.
PHARMACOPSYCHIATRY (2009)
Insulin like growth factor-1 and insulin like growth factor binding proteins in the cerebrospinal fluid and serum from patients with Alzheimer's disease
Zivar Salehi et al.
BIOFACTORS (2008)
Glucose-insulin homeostasis, lipid profiles and GH-IGF-IGFBP axis in clozapine-treated schizophrenic obesity versus non-psychiatric obesity
M-K Wu et al.
INTERNATIONAL JOURNAL OF OBESITY (2008)
Insulin and insulin-like growth factor-1 abnormalities in anti psychotic-naive schizophrenia
Ganesan Venkatasubramanian et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Associations of blood levels of insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-3 in schizophrenic Arab subjects
Abayomi O. Akanji et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2007)
Relationship between serum insulin-like growth factor-1 levels and Alzheimer's disease and vascular dementia
T Watanabe et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2005)
Insulin-like growth factor binding protein (IGFBP) signalling
JM Ricort
GROWTH HORMONE & IGF RESEARCH (2004)
Diagnosis and definition of treatment-resistant depression
M Fava
BIOLOGICAL PSYCHIATRY (2003)
Elevated levels of insulin, leptin, and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses
KI Melkersson et al.
JOURNAL OF CLINICAL PSYCHIATRY (2000)
Share Paper
